Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

HITACHI Supria Whole-body X-ray CT System Phase 3

K-Number: K163528 · 2017-03-03

Decision Date2017-03-03
Product CodeJAK
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

HITACHI Supria Whole-body X-ray CT System Phase 3 is a medical device manufactured by Hitachi Medical Systems America, Inc.. It received FDA 510(k) clearance on 2017-03-03 under approval number K163528. The device is classified under product code JAK. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the HITACHI Supria Whole-body X-ray CT System Phase 3?

HITACHI Supria Whole-body X-ray CT System Phase 3 is a medical device that received FDA 510(k) clearance on 2017-03-03. It is manufactured by Hitachi Medical Systems America, Inc.. The 510(k) number is K163528.

When was HITACHI Supria Whole-body X-ray CT System Phase 3 approved by the FDA?

HITACHI Supria Whole-body X-ray CT System Phase 3 received FDA 510(k) clearance on 2017-03-03, under approval number K163528.

What company makes HITACHI Supria Whole-body X-ray CT System Phase 3?

HITACHI Supria Whole-body X-ray CT System Phase 3 is manufactured by Hitachi Medical Systems America, Inc..

What is the FDA product code for HITACHI Supria Whole-body X-ray CT System Phase 3?

The FDA product code for HITACHI Supria Whole-body X-ray CT System Phase 3 is JAK.

Related Clinical Trials

Other Devices by Hitachi Medical Systems America, Inc.

Related Devices (Code: JAK)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.